An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer

Clinical trial NCT04089553 · COMPLETED

Trial details

NCT number: NCT04089553
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Start date: 2019-08-29
Primary completion: 2021-06-16
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.